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Vanadium is a metal widely distributed in the envi-
ronment. Although vanadate-containing compounds ex-
ert potent toxic effects on a wide variety of biological
systems, the mechanisms controlling vanadate-induced
adverse effects remain to be elucidated. The present
study investigated the vanadate-induced p53 activation
and involvement of reactive oxygen species (ROS) in p53
activation as well as the role of p53 in apoptosis induc-
tion by vanadate. Exposure of mouse epidermal JB6
cells to vanadate led to transactivation of p53 activity in
a time- and dose-dependent manner. It also caused mi-
tochondrial damage, apoptosis, and generated ROS.
Scavenging of vanadate-induced H2O2 by N-acetyl-L-cys-
teine (a general antioxidant) or catalase (a specific H2O2
inhibitor), or the chelation of vanadate by deferoxam-
ine, resulted in inhibition of p53 activation and cell mi-
tochondrial damage. In contract, an increase in H2O2
generation in response to superoxide dismutase or
NADPH enhanced these effects caused by vanadate.
Furthermore, vanadate-induced apoptosis occurred in
cells expressing wild-type p53 (p531/1) but was very
weak in p53-deficient (p532/2) cells. These results dem-
onstrate that vanadate induces p53 activation mainly
through H2O2 generation, and this activation is required
for vanadate-induced apoptosis.
The p53 tumor suppressor protein is a transcription factor
that enhances the transcriptional rate of several genes known
to play a critical role in transducing signals from DNA damage
(1–5). It is elevated in response to genotoxic agents, such as
ionizing radiation, UV light, or certain chemicals (1, 4, 6). The
activation of p53 has been implicated in cell cycle control, DNA
repair, and apoptosis (5–7). The function of p53 is regulated at
the levels of transcription, translation, protein turnover, and
cellular compartmentalization, as well as association with
other proteins (8). In addition, growing evidence indicates that
the ability of p53 to inhibit diverse regulatory functions is
likely to depend on its phosphorylation, which is conformation-
dependent (8, 9). p53 phosphorylation is mediated by a variety
of protein kinases, including casein kinase I, casein kinase II,
protein kinase A, CDK7, DNA-activated protein kinase, protein
kinase C, c-Jun NH2-terminal kinases, extracellular signal-
regulated kinases, and p38 kinase (8–10).
Apoptosis, or programmed cell death, has been characterized
as a fundamental cellular activity occurring under a wide range
of physiological and pathological conditions (1–4, 11, 12). It is
essential in many physiological processes, including matura-
tion and effector mechanisms of the immune system, embry-
onic development, and hormone-dependent tissue remodeling
(11–15). Inappropriate regulation of apoptosis may play an
important role in many pathological conditions such as hepa-
totoxicity, ischemia, stroke, heart disease, cancer, AIDS, auto-
immunity, and degenerative diseases of the central nervous
system (16–18).
Vanadium is a transition metal widely distributed in envi-
ronment. Occupational exposure to vanadium is common in
oil-fired electrical generating plants and the petrochemical,
steel, and mining industries (19, 20). It has been found that
vanadate-containing compounds exert potent toxic and carci-
nogenic effects, such as DNA damage and cell transformation
(21–23). Normally, if the cell is damaged by external agents,
such as vanadate, it will respond to such damage by activating
signal transduction pathways that control the activation of
transcription factors and the regulation of gene expression as
well as transiently delaying cell cycle progression to allow the
repair of damaged DNA. If the cell damage is severe and cannot
be repaired, the cells will undergo apoptosis. Therefore, apo-
ptosis plays an essential role as a protective mechanism
against neoplastic development in the organism by eliminating
genetically damaged or improperly proliferating cells. Investi-
gation of the mechanism of carcinogen-induced apoptosis is
very important for understanding overall carcinogenesis. It has
been demonstrated that vanadate-mediated generation of re-
active oxygen species (ROS)1 plays an important role in its
adverse biological effects (24–27). Our previous studies also
indicate that generation of H2O2 by vanadate is a mediator for
apoptosis induction in a cell culture model (24). The present
study investigated the p53 transactivation and its mechanisms
as well as its role in apoptosis induction by vanadate.
MATERIALS AND METHODS
Reagents—Sodium metavanadate (vanadate) was purchased from
Aldrich; deferoxamine, N-acetyl-L-cysteine (NAC), NADPH, superoxide
dismutase (SOD), and sodium formate were purchased from Sigma;
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JC-1, DiOC6, DCFH-DA, and dihydroethidium (HE) were purchased
from Molecular Probes (Eugene, OR); luciferase assay substrate was
obtained from Promega; fetal bovine serum (FBS), Eagle’s minimal
essential medium (MEM), and Dulbecco’s modified Eagle’s medium, as
well as RPMI 1640 were from BioWhittaker.
Cell Culture—The JB6 P1 mouse epidermal cell line (Cl 41) and its
stable p53 luciferase reporter plasmid transfectant (Cl 41 p53 cells)
were cultured in monolayers at 37 °C under 5% CO2 using MEM con-
taining 5% fetal calf serum, 2 mM L-glutamine, and 25 mg/ml gentamicin
(28–30). Normal embryo fibroblasts (p531/1) or p53-deficient embryo
fibroblasts (p532/2) were cultured in Dulbecco’s modified Eagle’s me-
dium with 10% FBS, 2 mM L-glutamine, and 25 mg/ml gentamicin (31).
Assay for p53 Activity—Confluent monolayers of Cl 41 p53 cells were
trypsinized, and 8 3 103 viable cells were suspended in 100 ml 5%
FBS/MEM. The cells were added into each well of a 96-well plate. Plates
were incubated at 37 °C in a humidified atmosphere of 5% CO2. Twelve
to 24 h later, cells were starved by culturing them in 0.1% FBS/MEM for
12 h. The cells were exposed for 24 h to different concentrations of
vanadate for p53 induction. The cells were extracted with lysis buffer,
and luciferase activity was measured using a luminometer (Monolight
3010). The results were expressed as p53 activity relative to controls
(5, 6, 30).
DNA Fragmentation Assay—Cl 41 cells were exposed to ultraviolet C
(60 J/m2) or treated with different concentrations of vanadate for 24 h.
All the cells were harvested by centrifugation and lysed with a lysis
buffer (5 mM Tris-HCl, pH 8.0; 20 mM EDTA; 0.5% Triton X-100) on ice
for 45 min. Fragmented DNA in the supernatant (after a centrifugation
at 14,000 rpm for 30 min at 4 °C) was extracted twice with phenol/
chloroform/isoamyl alcohol (25:24:1, v/v/v) and once with chloroform
before precipitating with ethanol and salt. The DNA pellet was washed
once with 70% ethanol and resuspended in TE buffer, pH 8.0, with 100
mg/ml RNase at 37 °C for 2 h. The DNA fragments were separated by
1.8% agarose gel electrophoresis and visualized under UV light as
described previously (5, 6).
DNA Fragment End Labeling Assay—The cells were treated with
vanadate for 24 h. The cells were then harvested. The DNA fragment
end labeling assays were performed as described in the protocol by the
manufacturer using an in situ cell death detection kit employing fluo-
rescein (Roche Molecular Biochemicals). The cells were analyzed by
flow cytometry.
Mitochondria Transmembrane Potential (Dcm) Assay—JC-1 and
DiOC6 are two specific fluorescent dyes used to test the cell mitochon-
drial membrane potential (32). The cells were seeded in 6-well plates
and cultured until 90% confluent. The cells were then treated with
vanadate for 12 h. The dye, JC-1 or DiOC6 (dissolved in Me2SO and
diluted with PBS to final concentrations of 10 mg/ml or 40 nM, respec-
tively), was applied to the cells and incubated for another 15–20 min at
37 °C. The cells were washed twice with PBS and harvested for analysis
by flow cytometry.
Cellular Superoxide (O2
.) and H2O2 Staining Assay—HE is a specific
O2
. dye (32), and DCFH-DA has been frequently used to monitor H2O2
levels in cells (32). The cells were seeded in 6-well plates and cultured
until 90% confluent. The cells were then treated with vanadate for 12 h.
HE or DCFH-DA (both dissolved in Me2SO and diluted with PBS to
final concentrations of 5 and 5 mM, respectively) was applied to the cells
and incubated for another 15–20 min at 37 °C. The cells were washed
twice with PBS and harvested for analysis by flow cytometry.
Electron Spin Resonance (ESR) Measurements—ESR measurements
were carried out using a Varian E9 ESR spectrometer and a flat cell
assembly. Hyperfine couplings were measured (0.1 G) directly from
magnetic field separation using potassium tetraperoxochromate
(K3CrO8) and 1,1-diphenyl-2-picrylhydrazyl as reference standards.
Cl41 cells (1 3 106) were mixed with 100 mM 5,5-dimethyl-1-pyrroline
N-oxide, 100 mM NADPH, and 1 mM vanadate. The reaction mixture
was then transferred to a flat cell for ESR measurement as described
previously (19, 26).
RESULTS
Activation of p53 Transactivation Activity by Vanadate—To
investigate the possible activation of p53 by vanadate, we ex-
posed the well characterized JB6 cell with PG13-luciferase
reporter stable transfectants to vanadate (5, 6, 30). The results
show that vanadate markedly activated p53-dependent tran-
scription activity in a time- and dose-dependent manner (Fig.
1). The maximum induction of p53 activity occurred between 36
and 48 h after cell exposed to vanadate (Fig. 1B). These results
demonstrated that vanadate is a stimulus for p53 transactiva-
tion. It may noted that these data are different from previous
reports that indicate that at a concentration of 1 mM, vanadate
decreased (35), whereas at a concentration of 10 mM, vanadate
did not exhibit any observable (36) effects on p53 mRNA levels
in human cancer HeLa cells and C127 mouse tumor cells,
respectively. These differences may be due to different cell lines
and doses used among these studies. This was supported by our
study that 10 mM vanadate had no effects on p53 activity in JB6
cells (data not shown).
Generation of Reactive Oxygen Species Is Required for p53
Activation by Vanadate—It has been reported that vanadate
may generate ROS under some circumstances (24). To study
the relationship between ROS generation and p53 activation,
vanadate-induced ROS production was determined either by
dye staining or ESR. Fig. 2A showed that cells alone did not
generate any detectable amount of free radicals, whereas a
mixture of cells and vanadate generated a strong ESR spec-
trum (Fig. 2B). The spectrum consists of a 1:2:2:1 quartet with
hyperfine splittings of aH 5 aN 5 14.9 G, where aN and aH
denote hyperfine splittings of the nitroxyl nitrogens and a-hy-
FIG. 1. Induction of p53-dependent transcription activity by
vanadate. JB6, Cl 41, and PG13-luciferase (PG13-luc) stable transfec-
tant (Cl 41 p53) cells, suspended in 5% FBS/MEM, were added to each
well of 96-well plates and cultured overnight. A, for the dose-response
study, the cells were treated for 30 h with vanadate at the concentra-
tions indicated. B, for time course study, the cells were treated with 200
mM vanadate for various time points as indicated. The asterisk indicates
a significant increase from control (p , 0.05). p53 activity was deter-
mined by the luciferase activity assay. The results are presented as
relative p53 activity. Each point and bar indicates the mean 6 S.D.
from triplicate assays.
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drogen, respectively. Based on these splittings and the 1:2:2:1
line shape, the spectrum was assigned to the DMPO-OH ad-
duct, which is evidence of zOH radical generation. Addition of
catalase, a scavenger of H2O2, inhibited zOH radical generation
(Fig. 2C), indicating that H2O2 was produced in the vanadate-
treated cells and served as a precursor of zOH generation.
Addition of sodium formate, an zOH radical scavenger, de-
creased the signal intensity (Fig. 2D), confirming that the
1:2:2:1 quartet observed in this study was due to zOH genera-
tion. Incubation of the mixture with deferoxamine, a metal
chelator, dramatically decreased the signal intensity (Fig. 2E),
indicating a key role of vanadate in the radical generation.
Measurements using HE, a specific fluorescent dye for O2
., or
DCFH-DA, a fluorescent dye for H2O2, demonstrate that incu-
bation of cells with vanadate led to an increase in the genera-
tion of both O2
. (increasing percentage of positive cells from 48.7
to 75.2%) and H2O2 (increasing percentage of positive cells
from 50.4 to 63.5%) (Figs. 3, A and B). To investigate the
possible role of ROS in p53 activation by vanadate, the effect of
specific modifiers of ROS on vanadate-induced p53 activation
was determined. The results show that pretreatment of cells
with NAC, catalase, or deferoxamine caused inhibition of van-
adate-induced p53 activation (p , 0.05) (Fig. 4), whereas in-
creasing H2O2 generation with the addition of SOD or NADPH
enhanced p53 activation (p , 0.05) (Fig. 4). These effects on
vanadate-induced p53 activation are consistent with the effects
on ROS generation (Fig. 2). These data support the hypothesis
that ROS generation by vanadate is required for its activation
of p53. It is noted that treatment of cell with sodium formate
not only did not inhibits vanadate-induced p53 activation but
also enhanced vanadate-induced p53 activation (Fig. 4).
Induction of Apoptosis by Vanadate—p53 is believed to be
crucial in the induction of apoptosis in human and murine cells
following DNA damage (5, 6, 8). This notion was supported by the
findings that apoptosis of both thymocytes and intestinal crypt
cells following irradiation was blocked in p53-deficient mice (5, 6,
37, 38). To study the molecular basis of vanadate-induced apo-
ptosis, we established an apoptosis model using JB6 Cl 41 cells.
The results from DNA fragmentation assay showed that treat-
ment of cells with vanadate indeed caused a dose-dependent
induction of apoptosis in Cl 41 cells (Figs. 5A). Flow cytometric
analysis of DNA fragment end labeling indicated that apoptosis
increased by 11.6, 38.2, and 51.8% at the concentrations of 50,
100, and 400 mM, respectively (Fig. 5B), whereas the control
group only had 3.0% positive cells. It was noted that apoptosis
induction at 400 mM vanadate was higher than that at 200 mM,
whereas p53 activation at 400 mM is less than that at 200 mM. The
explanation for this is that there were more apoptotic cells at 400
mM than at 200 mM, which resulted in less p53 activity observed at
400 mM. Exposure of the human lung cell line (A549) to 200 mM
vanadate also increased apoptosis by 35.6% (Fig. 5C). These
results suggest that vanadate-induced apoptosis is not only lim-
ited in mouse epidermal Cl 41 cells.
Induction of Mitochondrial Damage by Vanadate—Mito-
chondrial damage is a key step for apoptosis in many experi-
mental systems (32–34). Changes of mitochondrial transmem-
brane potential (Dcm) have been considered an indicator of
mitochondrial damage (32–34). JC-1 and DiOC6 are two dyes
widely used for determination of Dcm (32–34). We employed
these dyes and found that treatment of cells with vanadate
resulted in a significant decrease in Dcm as measured by JC-1
staining (from 61.6 to 19.3%) and DiOC6 staining (from 38.9 to
6.0%) (Fig. 6). These data indicate that vanadate causes mito-
chondrial membrane damage.
ROS-mediated p53 Activation Plays an Essential Role in
Mitochondrial Damage and Apoptosis by Vanadate—To study
the ROS-mediated p53 activation in vanadate-induced mito-
chondrial damage, the cells were preincubated with various
ROS modifiers for 30 min, and then the cells were used to study
mitochondrial damage in response to vanadate. As shown in
Fig. 7, the effects of these ROS modifiers on Dcm changes are in
agreement with their effects on vanadate-induced p53 activa-
tion (Fig. 7).
To obtain direct evidence for the involvement of ROS-medi-
ated p53 activation in vanadate-induced apoptosis, we used two
fibroblast cell lines, p531/1 and p532/2, which were derived
from mouse embryos containing either wild-type p53 (p531/1)
or were p53-deficient (p532/2) as reported previously (5, 6, 31).
p531/1 fibroblasts exhibited increases of apoptosis by 41.6,
36.6, and 25.7% at vanadate doses of 800, 200, or 50 mM,
respectively, whereas p532/2 cells showed very weak re-
sponses (16.0, 9.0, and 0.0% at vanadate doses of 800, 200, or 50
mM, respectively) (Fig. 8). These results demonstrate that p53
activation mediated by H2O2 is required for vanadate-induced
apoptosis. We also observed that there are some apoptotic cells
in p53-deficient cells, revealing that there may be some other
pathways involved in vanadate-induced apoptosis.
DISCUSSION
We reported previously that vanadate can generate ROS,
which are considered to be involved in apoptosis induction (24).
However, the molecular mechanisms of apoptosis caused by
vanadate-generated ROS remain to be investigated. The re-
sults presented in this study demonstrate that ROS generated
by vanadate mediate p53 activation and mitochondrial dam-
age, which subsequently leads to cell apoptosis. This conclusion
is based on the observations that exposure of cells to vanadate
resulted in activation of p53 activity, generation of ROS, and a
decrease in mitochondrial transmembrane potential as well as
cell apoptosis. Reduction of vanadate-induced H2O2 by cata-
lase, NAC, or deferoxamine inhibited the p53 activation and
cell mitochondrial damage induced by vanadate. In contrast,
increasing H2O2 generation with SOD or NADPH promoted
p53 activation and mitochondrial damage. Furthermore, van-
adate-induced apoptosis occurred at a much higher level in
cells expressing wild-type p53 (p531/1) than in p53-deficient
(p532/2) cells.
It is well accepted that extracellular stimuli trigger signals
through a cascade of protein-protein interactions (1–5, 39–41).
It is generally believed that these extracellular stimuli gener-
ate and/or require reactive free radicals or derived oxidant
species to transmit successfully their signals to the nucleus (40,
42). Naturally occurring free radicals typically include ROS
and reactive nitrogen species (40). In addition to inducing cel-
lular injury, such as DNA damage and lipid peroxidation, free
radicals also function as intracellular messengers (19, 40, 43).
FIG. 2. Measurement of vanadate-induced ROS generation by
ESR. ESR spectra were recorded 6 min after mixing 1 3 106 Cl 41 cells,
100 mM 5,5-dimethyl-1-pyrroline N-oxide, 1 mM sodium vanadate, and
100 mM NADPH with or without different ROS scavengers as indicated.
The final concentrations of these scavengers were catalase, 2000 units/
ml; SOD, 0.5 mg/ml; or sodium formate, 100 mM. Deferoxamine, 2 mM,
was used as a metal chelator.
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More and more data are accumulating to indicate a vital role of
ROS in mediating cellular responses by various extracellular
stimuli (19, 24, 26, 32, 40, 43). It has been reported that free
radicals are involved in the production of cytokines, growth
factors, and hormones in the activation of nuclear transcription
factors, in gene transcription, in neuromodulation, and in apo-
ptosis (19, 40, 43). For example, it has been reported that
generation of H2O2 is required for platelet-derived growth fac-
tor signal transduction (44). The evidence suggesting the in-
volvement of ROS in apoptosis includes the following: 1) the
addition of ROS or deletion of endogenous antioxidants can
induce apoptosis; 2) apoptosis can be inhibited by endogenous
or exogenous antioxidants in some cases; and 3) apoptosis is
associated with increases in cellular ROS levels (45). Our pre-
vious studies have indicated that vanadate can generate ROS,
which are considered to be involved in apoptosis induction (24).
The results presented here demonstrate that increased intra-
cellular H2O2 levels and activation of p53 activity were de-
tected upon incubation of cells with vanadate. Pretreatment of
cells with NAC or catalase prevented the increase in ROS and
resulted in inhibition of p53 activation by vanadate. In con-
trast, increasing H2O2 levels with SOD or NADPH led to higher
levels of p53 activation. These data suggest that H2O2 plays an
essential role in vanadate-induced p53 activation. Although the
details of molecular mechanism for involvement of H2O2 in p53
activation by vanadate are not clear, it is reasonable to hypoth-
esize that H2O2-mediated DNA damage and activation of other
signal transduction pathways, such as mitogen-activated pro-
tein kinase family, may cause an increased p53 protein expres-
sion and p53 protein phosphorylation, respectively. It should be
noted that pretreatment of cells with sodium formate enhanced
p53 activation by vanadate. These data are consistent with our
previous finding that sodium formate promotes vanadate-in-
duced apoptosis, supporting our notion that zOH is not the
positive regulator for p53 activation by vanadate. The expla-
nation for enhancing effects of vanadate-induced p53 activation
by sodium formate may be due to other pathways by which zOH
feedback down-regulates p53 activation. Our next study will
focus on this issue.
Alteration of mitochondrial function has been linked to cell
apoptosis in most cases. An inhibition of oxidative ATP produc-
tion has been reported to be associated with glucocorticoid-
induced lymphocyte apoptosis (46). A decrease in the ability of
mitochondrial dehydrogenase to cleave tetrazolium salt (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) has
been demonstrated in anti-CD3-induced apoptosis of T cells
(33). In the case of tumor necrosis factor-a-induced apoptosis,
early disruption of mitochondrial function has also been de-
scribed (34). Detailed study has indicated that alterations of
mitochondrial functions include an early decrease in Dcm, a
drop in the rate of mitochondrial translation and defect in
FIG. 4. Effects of free radical scavengers on p53 activation by
vanadate. JB6, Cl 41, and PG13-luciferase (PG13-luc) stable transfec-
tant (Cl 41 p53) cells suspended in 5% FBS/MEM were added to each
well of 96-well plates and cultured overnight. The cells were pretreated
with different free radical modifiers at the concentrations indicated.
The cells were then exposed to vanadate (100 mM) for 24 h. The p53
activity was determined by the luciferase activity assay. The results are
presented as relative p53 activity. Each column and bar indicates the
mean 6 S.D. from triplicate assays. The * indicates a significant in-
crease from control; ’ indicates a significant decrease from vanadate;
and ** indicates a significant increase from vanadate (p , 0.05).
FIG. 3. Determination of O2
. and
H2O2 by HE and DCFH-DA staining.
Cl 41 cells were seeded in 6-well plates
and cultured until 90% confluent. The
cells were then treated with vanadate for
60 min. HE (A) or DCFH-DA (B) was ap-
plied to the cells and incubated for an-
other 15–20 min at 37 °C. The cells were
washed twice with PBS and harvested for
analysis by flow cytometry. a and c are
HE and DCFH-DA controls, respectively;
b and d are cells with 200 mM vanadate
treatment.
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mitochondrial protein cytoplasmic precursor maturation (47).
Among all of these changes, the decrease in Dcm may be most
tightly associated with cell apoptosis. Indeed, overexpression of
Bcl-2 or treatment of cells with ionophore nigericin resulted in
both an increase in Dcm and the inhibition of apoptosis (48).
The data from the current investigation demonstrate a drop in
Dcm after exposure of cells to vanadate. This alteration of
mitochondrial function could be blocked by either scavenging
H2O2 or deletion of the p53 gene. These data therefore indicate
that generation of ROS is required for vanadate-induced mito-
chondrial damage.
Apoptosis is a naturally occurring process of cell “suicide”
that plays a critical role in the development and maintenance
of metazoans by eliminating superfluous or unwanted cells
(1–4, 11–12). Disruption of apoptosis plays a major role in
diseases such as cancer, AIDS, autoimmune disease, and neu-
rodegeneration (11–18). The biochemical machinery for apo-
ptotic cell death is constitutively present in virtually all mam-
malian cells and can be activated by a wide variety of extra- or
intracellular signals (1–6, 24). Although numerous investiga-
tions have been dedicated to the elucidation of apoptosis initi-
ation and regulation, fundamental questions concerning the
FIG. 5. Induction of apoptosis by vanadate. A and B, subconfluent (80–90%) monolayers of JB6 Cl 41 cells in 100-mm dishes were subjected
to either ultraviolet C (UVC) (120 J/m2, positive control) or different concentrations of vanadate for 30 h. Then both detached and attached cells
were harvested. A, DNA fragmentation assays were carried out as described under “Materials and Methods”; B, DNA fragment end labeling assays
were performed as described using an in situ cell death detection kit employing fluorescein (Roche Molecular Biochemicals). The cells were
analyzed by flow cytometry. The concentrations of vanadate used were as follows: a, medium control; b, 50 mM; c, 100 mM; and d, 400 mM. C, A549
cells were treated with vanadate for 30 h. The cells were harvested, and DNA fragment end labeling assays were carried out using the same method
described in B. The concentrations of vanadate used were as follows: a, medium control; b, 200 mM vanadate.
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molecular and biochemical mechanisms of apoptosis elicited by
different stimuli remain to be understood. Vanadate has been
reported to be an agent with potent toxic effects in a wide
variety of experimental systems (21–24). It has been shown to
cause DNA mutations and DNA-protein cross-links and apo-
ptosis (21–24). Some previous studies have suggested that va-
nadium-mediated generation of ROS may be involved in toxic-
ity and apoptosis induced by this metal (24–27). In the present
investigation, we demonstrated that through H2O2-mediated
reaction vanadate is able to cause p53 activation, which is
required for apoptosis induction by vanadate.
In summary, the results presented in the present study
FIG. 6. Mitochondrial damage in-
duced by vanadate. Cl 41 cells were
seeded in 6-well plates and cultured until
90% confluent. The cells were then
treated with vanadate for 12 h. The dye
JC-1 (A) or DiOC6 (B) dissolved in Me2SO
and diluted with PBS to final concentra-
tions of 10 mg/ml or 40 nM, respectively,
was applied to the cells and incubated for
another 15–20 min at 37 °C. The cells
were washed twice with PBS and har-
vested for analysis by flow cytometry. a
and c are JC-1 and DiOC6 controls, re-
spectively, and b and d are cells treated
with 200 mM vanadate.
FIG. 7. Effects of free radical modi-
fiers on the decrease in mitochon-
drial transmembrane potential in-
duced by vanadate. Cl 41 cells
suspended in 5% FBS/MEM were added
to each well of 6-well plates and cultured
overnight. The cells were pretreated with
different free radical modifiers as indi-
cated for 30 min. The final concentrations
of these modifiers are as follows: catalase,
5 3 104 units/ml; SOD, 250 units/ml; so-
dium formate, 300 mM; or deferoxamine, 2
mM. The cells were exposed to vanadate at
200 mM for 12 h. The dye JC-1 was applied
to the cells at a final concentration of 10
mg/ml. The cells were incubated for an-
other 15–20 min at 37 °C, washed twice
with PBS, and then harvested for analy-
sis flow cytometry. The percentages of
positive cells are as follows: a, 40.7% for
JC-1 control; b, 24.8% for vanadate; c,
45.1% for vanadate 1 deferoxamine; d,
8.3% for vanadate 1 SOD; e, 33.6% for
vanadate 1 catalase; and f, 23.5% for van-
adate 1 sodium formate.
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demonstrate that vanadate induces generation of H2O2, which
is required for p53 transactivation. This H2O2-mediated p53
activation appears to play an essential role in vanadate-in-
duced apoptosis.
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FIG. 8. Vanadate induces apoptosis
in p531/1 but not in p532/2 fibro-
blasts. Subconfluent (80–90%) monolay-
ers of p531/1 or p532/2 fibroblast in
100-mm dishes were subjected to differ-
ent concentrations of vanadate for 24 h.
The cells were then harvested, and DNA
fragment end labeling assays were per-
formed as described by using an in situ
cell death detection kit. The cells were
analyzed by flow cytometry.
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